PHASE I STUDY OF TRIPLE DRUG COMBINATION OF CPT-11 (C), OXALIPLATIN (O) AND TOMUDEX (T) (COT) IN PREVIOUSLY UNTREATED PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC): NATIONAL CANCER INSTITUTE OF CANADA CLINICAL TRIALS GROUP (NCIC CTG), IND.135

571

  • Maroun, Jean A
  • Jonker, Derek
  • Goel, Rakesh
  • Cripps, M. C
  • Dent, Susan F

  • Bryn Fisher, Lesley Seymour, Walter Kocha, Ottawa Regional Cancer Centre, Ottawa, ON, Canada; NCIC CTG, Kingston, ON, Canada; London Regional Cancer Centre, London, ON, Canada

Onkologie 25:p 15, August 2002.
Copyright © 2002 S. Karger AG, Basel
View full text|Download PDF